|
|
| Acesso ao texto completo restrito à biblioteca da Embrapa Agroindústria de Alimentos. Para informações adicionais entre em contato com ctaa.biblioteca@embrapa.br. |
Registro Completo |
Biblioteca(s): |
Embrapa Agroindústria de Alimentos. |
Data corrente: |
18/06/2021 |
Data da última atualização: |
24/06/2021 |
Tipo da produção científica: |
Artigo em Periódico Indexado |
Autoria: |
LANDIM, A. P. M.; MATSUBARA, N. K.; SILVA-SANTOS, J. E. da; SILVA, C. M.; ROSENTHAL, A. |
Afiliação: |
ANA P. M. LANDIM, UFRRJ; NATÁLIA K. MATSUBARA, UFSC; JOSE E. DA SILVA-SANTOS, UFSC; CAROLINE MELLINGER SILVA, CTAA; AMAURI ROSENTHAL, CTAA. |
Título: |
Application of preliminary high-pressure processing for improving bioactive characteristics and reducing antigenicity of whey protein hydrolysates. |
Ano de publicação: |
2021 |
Fonte/Imprenta: |
Food Science and Technology International, 2021. |
DOI: |
https://doi.org/10.1177/10820132211022106 |
Idioma: |
Inglês |
Notas: |
First Published June. |
Conteúdo: |
This study investigated the use of Novo Pro-D® (NPD) and Ficin (FC) as alternative proteases for the production of bioactive peptides with reduced allergenicity from whey protein concentrate (WPC). In addition, the use of high hydrostatic pressure processing as pre-treatment of WPC and its impact on the final characteristics of hydrolysates were also evaluated. NPD treatments generated hydrolysates with a 98% reduction of soluble proteins, greater in vitro antioxidant capacity, and less immunoreactivity when compared to FC ones. However, pre-treatment was an essential tool to improve WPC hydrolysis when FC was used, resulting in hydrolysates with less soluble proteins, enhanced antioxidant capacity, and less allergenicity compared with conventional hydrolysis. As for NPD, the pre-treatment of WPC improved the in vitro antioxidant capacity and resulted in a 100% reduction in immunoreactivity to ?-lactoglobulin in a shorter processing time. Importantly, bioactive peptides generated by FC displayed an improved ability to induce in vitro arterial relaxation, compared with those obtained from NPD process. Therefore, this study provides innovative evidence regarding how the proteases used for production of whey hydrolysates can improve its biological effects, and discloses the use of high hydrostatic pressure combined with enzymatic hydrolysis as a promising alternative to produce hydrolysates with improved properties. |
Palavras-Chave: |
In vitro allergenicity; In vitro antioxidant capacity; Whey protein hydrolysates. |
Thesaurus Nal: |
Enzymatic hydrolysis; Food technology; Vasodilation. |
Categoria do assunto: |
Q Alimentos e Nutrição Humana |
Marc: |
LEADER 02339naa a2200265 a 4500 001 2132400 005 2021-06-24 008 2021 bl uuuu u00u1 u #d 024 7 $ahttps://doi.org/10.1177/10820132211022106$2DOI 100 1 $aLANDIM, A. P. M. 245 $aApplication of preliminary high-pressure processing for improving bioactive characteristics and reducing antigenicity of whey protein hydrolysates.$h[electronic resource] 260 $c2021 500 $aFirst Published June. 520 $aThis study investigated the use of Novo Pro-D® (NPD) and Ficin (FC) as alternative proteases for the production of bioactive peptides with reduced allergenicity from whey protein concentrate (WPC). In addition, the use of high hydrostatic pressure processing as pre-treatment of WPC and its impact on the final characteristics of hydrolysates were also evaluated. NPD treatments generated hydrolysates with a 98% reduction of soluble proteins, greater in vitro antioxidant capacity, and less immunoreactivity when compared to FC ones. However, pre-treatment was an essential tool to improve WPC hydrolysis when FC was used, resulting in hydrolysates with less soluble proteins, enhanced antioxidant capacity, and less allergenicity compared with conventional hydrolysis. As for NPD, the pre-treatment of WPC improved the in vitro antioxidant capacity and resulted in a 100% reduction in immunoreactivity to ?-lactoglobulin in a shorter processing time. Importantly, bioactive peptides generated by FC displayed an improved ability to induce in vitro arterial relaxation, compared with those obtained from NPD process. Therefore, this study provides innovative evidence regarding how the proteases used for production of whey hydrolysates can improve its biological effects, and discloses the use of high hydrostatic pressure combined with enzymatic hydrolysis as a promising alternative to produce hydrolysates with improved properties. 650 $aEnzymatic hydrolysis 650 $aFood technology 650 $aVasodilation 653 $aIn vitro allergenicity 653 $aIn vitro antioxidant capacity 653 $aWhey protein hydrolysates 700 1 $aMATSUBARA, N. K. 700 1 $aSILVA-SANTOS, J. E. da 700 1 $aSILVA, C. M. 700 1 $aROSENTHAL, A. 773 $tFood Science and Technology International, 2021.
Download
Esconder MarcMostrar Marc Completo |
Registro original: |
Embrapa Agroindústria de Alimentos (CTAA) |
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
URL |
Voltar
|
|
| Acesso ao texto completo restrito à biblioteca da Embrapa Gado de Leite. Para informações adicionais entre em contato com cnpgl.biblioteca@embrapa.br. |
Registro Completo
Biblioteca(s): |
Embrapa Gado de Leite. |
Data corrente: |
07/02/2013 |
Data da última atualização: |
05/03/2013 |
Tipo da produção científica: |
Artigo em Anais de Congresso |
Autoria: |
GUIMARAES, A. S.; LANGE, C. C.; O'CONNOR, A. M.; CASTANHEIRA, R. G.; HERRMANN, G. P.; VARGAS, A. C.; LIBARDONI, F.; MOSQUEIRA, V. C. F.; SOUZA, G. N. de; MENDONCA, L. C.; BRITO, M. A. V. P. e; GERN, J. C.; BRANDAO, H. de M. |
Afiliação: |
ALESSANDRO DE SA GUIMARAES, CNPGL; CARLA CHRISTINE LANGE, CNPGL; A. M. O'CONNOR, IOWA STATE UNIVERSITY; R. G. CASTANHEIRA, UFOP; G. P. HERRMANN, UFSM; A. C. VARGAS, UFSM; F. LIBARDONI, UFSM; V. C. F. MOSQUEIRA, UFOP; GUILHERME NUNES DE SOUZA, CNPGL; LETICIA CALDAS MENDONCA, CNPGL; MARIA APARECIDA V PAIVA E BRITO, CNPGL; JULIANA CARINE GERN, CNPGL; HUMBERTO DE MELLO BRANDAO, CNPGL. |
Título: |
Cloxacillin nanostructures formulation for control of clinical bovine keratoconjunctivitis. |
Ano de publicação: |
2012 |
Fonte/Imprenta: |
In: Simpósio Embrapa LabEx EUA de Sanidade Animal, 2., 2012, Brasília. Proceedings... Brasília: Embrapa Estudos e Capacitação, 2012 |
Páginas: |
p. 62 |
Idioma: |
Inglês |
Palavras-Chave: |
Infecção de queratoconjuntivite; Nanoparticulas mucoadesivas. |
Thesagro: |
Moraxella Bovis. |
Categoria do assunto: |
H Saúde e Patologia |
Marc: |
LEADER 00972naa a2200301 a 4500 001 1948723 005 2013-03-05 008 2012 bl uuuu u00u1 u #d 100 1 $aGUIMARAES, A. S. 245 $aCloxacillin nanostructures formulation for control of clinical bovine keratoconjunctivitis. 260 $c2012 300 $ap. 62 650 $aMoraxella Bovis 653 $aInfecção de queratoconjuntivite 653 $aNanoparticulas mucoadesivas 700 1 $aLANGE, C. C. 700 1 $aO'CONNOR, A. M. 700 1 $aCASTANHEIRA, R. G. 700 1 $aHERRMANN, G. P. 700 1 $aVARGAS, A. C. 700 1 $aLIBARDONI, F. 700 1 $aMOSQUEIRA, V. C. F. 700 1 $aSOUZA, G. N. de 700 1 $aMENDONCA, L. C. 700 1 $aBRITO, M. A. V. P. e 700 1 $aGERN, J. C. 700 1 $aBRANDAO, H. de M. 773 $tIn: Simpósio Embrapa LabEx EUA de Sanidade Animal, 2., 2012, Brasília. Proceedings... Brasília: Embrapa Estudos e Capacitação, 2012
Download
Esconder MarcMostrar Marc Completo |
Registro original: |
Embrapa Gado de Leite (CNPGL) |
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
Fechar
|
Expressão de busca inválida. Verifique!!! |
|
|